Editing Biogen (section)

== Finances ==
For the fiscal year 2017, Biogen reported earnings of US$2.539 billion, with an annual revenue of US$12.274 billion, an increase of 7.2% over the previous fiscal cycle. Biogen's shares traded at over $289 per share, and its market capitalization was valued at over US$63 billion in November 2018.<ref>{{Cite web|title=Biogen Revenue 2006-2018 {{!}} BIIB|url=https://www.macrotrends.net/stocks/charts/BIIB/biogen/revenue|access-date=2018-11-05|website=Macro Trends}}</ref> The company ranked 228 on the 2021 [[Fortune 500]] list of the largest United States corporations by revenue.<ref>{{Cite web|url=http://fortune.com/fortune500/list/|title=Fortune 500 Companies 2021: Who Made the List|website=Fortune|language=en-US|access-date=2022-02-08|archive-date=2018-11-10|archive-url=https://web.archive.org/web/20181110190356/http://fortune.com/fortune500/list/|url-status=dead}}</ref>
{| class="wikitable float-left" style="text-align: right;"
!Year
!Revenue<br />in mil. USD$
!Net income<br />in mil. USD$
!Total Assets<br />in mil. USD$
!Price per Share<br />in USD$
!Employees
|-
|2005
|2,423
|161
|8,382
|39.89
|
|-
|2006
|2,683
|218
|8,553
|42.39
|
|-
|2007
|3,172
|638
|8,629
|52.16
|
|-
|2008
|4,098
|783
|8,479
|51.09
|
|-
|2009
|4,377
|970
|8,552
|45.11
|
|-
|2010
|4,716
|1,005
|8,092
|51.95
|
|-
|2011
|5,049
|1,234
|9,050
|84.78
|
|-
|2012
|5,516
|1,380
|10,130
|125.83
|
|-
|2013
|6,932
|1,862
|11,863
|198.43
|6,850
|-
|2014
|9,703
|2,935
|14,315
|293.10
|7,550
|-
|2015
|10,764
|3,547
|19,505
|324.99
|7,350
|-
|2016
|11,449
|3,703
|22,877
|258.27
|7,400
|-
|2017
|12,274
|2,539
|23,653
|289.19
|7,300
|-
|2018<ref>{{cite web|url=https://investors.biogen.com/static-files/30ea6b55-6a57-48ae-840d-96ac58ddf031 |title=2018 Annual Report |publisher=biogen.com |accessdate=17 March 2022}}</ref>
|13,453
|4,431
|25,289
|
|7,800
|-
|2019<ref>{{cite web|url=https://investors.biogen.com/static-files/f86236ee-b489-461e-bb28-b7b4ccc4aeea |title=2019 Annual Report |publisher=biogen.com |accessdate=17 March 2022}}</ref>
|14,378
|5,889
|27,234
|
|7,400
|-
|2020<ref>{{cite web|url=https://investors.biogen.com/static-files/0b109c48-3d3c-4554-8249-74b06c09797e |title=2020 Annual Report |publisher=biogen.com |accessdate=18 March 2022}}</ref>
|13,445
|4,001
|24,619
|
|9,100
|-
|2021<ref name="auto2">{{cite web|url=https://www.statista.com/statistics/274272/revenue-and-net-income-of-biogen-idec/ |title=Biogen's revenue from 2007 to 2023 |publisher=statista.com |accessdate=23 May 2024}}</ref>
|10,981
|1,556
|23,877
|
|
|-
|2022<ref name="auto2" />
|10,173
|3,046
|24,554
|
|
|-
|2023<ref name="auto2" />
|9,835
|1,161
|26,844
|
|
|}